logo
ENTITY

Oncolys Biopharma (4588 JP)

1
Analysis
Health Care • Japan
Oncolys BioPharma Inc. provides pharmaceutical and diagnostic products and services.. The Company researches, develops, manufactures and sells drugs targeting cancer and serious infectious diseases and also provides inspection services for viruses.
more
Exchange Announcement • 08 Nov 2024 12:00

Non-Consolidated Financial Results For The Nine Months Ended September 30, 2024 [Japanese Gaap]

Exchange Announcement • 09 Aug 2024 14:00

Non-Consolidated Financial Results For The Six Months Ended June 30, 2024 [Japanese Gaap]

Exchange Announcement • 06 Aug 2024 14:00

Announcement Of Complete Enrollment Of Phase I Clinical Trial For Telomelysin -Chemoradiation Combination Therapy

Exchange Announcement • 03 Jun 2024 14:00

First Patient Enrolled In Investigator Initiated Phase 2 Of Obp-301 With Pembrolizumab In Immunotherapy Refractory Esophagogastric Adenocarcinoma

Exchange Announcement • 10 May 2024 14:00

Non-Consolidated Financial Results For The Three Months Ended March 31, 2024 [Japanese Gaap]

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x